Becton, Dickinson And Company

Becton, Dickinson And Company Ids Division, doing business as Becton Dickinson & Co, is a manufacturer and prime contractor supplying infectious disease diagnostic equipment, blood culture systems, microbiology analyzers, molecular testing kits, and related laboratory reagents and consumables to federal healthcare agencies. The vendor operates as a subsidiary of parent company Becton, Dickinson And Co, a large for-profit manufacturer headquartered in Franklin Lakes, New Jersey, and competes on a full-and-open basis with no set-aside designations across its federal contracting footprint.

The Ids Division's capability portfolio centers on clinical diagnostic and laboratory products. Concrete representative work includes a $2.067 billion delivery order from the Defense Health Agency (issued October 2025) for microbiology analyzer services at Naval Hospital Jacksonville, Florida, extending through March 2031; a $998.1 million delivery order from the Defense Health Agency (September 2024) for BD MAX nucleic acid extraction devices and consumables serving Fort Belvoir, Virginia; a $749,000 blanket purchase agreement for laboratory blood culture testing cost-per-test services with Veterans Integrated Service Network 1 (August 2025); and a $678.7 million single-award BPA with Veterans Integrated Service Network 2 (November 2025) for blood culture analyzers and supplies under the GSA Schedule for Critical Analyzers, Laboratory (FSS-66-III). The division also delivers equipment maintenance services—a $157,064 purchase order from VISN 17 (September 2025) for BD FX blood culture system maintenance covering three instruments with onsite support through September 2030, and a $46,498 annual preventive maintenance contract from the Defense Health Agency (October 2024) for a BD Phoenix AP automated inoculum preparation instrument at Brooke Army Medical Center.

Customer concentration is heavily skewed toward defense and veterans healthcare. The Defense Logistics Agency Troop Support Medical leads by award count and dollar value (215 awards, $236.9 million combined potential value), followed by the Defense Health Agency (47 awards, $31.9 million), the Department of the Army Medical Command (65 awards, $21 million), VISN 4 (91 awards, $16 million), and VISN 5 (52 awards, $9.8 million). The top five customers by potential value account for approximately 32 percent of combined potential value. By award count, the same group plus Indian Health Service and NIAID represent 21 percent of awards. The vendor also holds scattered awards from the National Heart, Lung, and Blood Institute, the NIH Clinical Center, the National Cancer Institute, the Indian Health Service, and the Military Sealift Command—indicating broad federal healthcare reach but dominant concentration in VA and DoD medical supply chains.

The vendor positions primarily on the GSA Schedule for Critical Analyzers, Laboratory (FSS-66-III), which anchors 402 task orders carrying $53.9 million in combined potential value. Secondary IDVs include the Defense Logistics Agency indefinite delivery contract SPE2DE21D0029 (92 task orders, $132 thousand combined potential value), an In-Vitro Diagnostics, Reagents, Test vehicle (76 task orders, $2.2 million), and other DLA and Army Medical Command IDIQs. The vendor holds multiple single-award blanket purchase agreements with individual VA VISNs and the Defense Health Agency, structured as master vehicles enabling streamlined task-order issuance for diagnostic equipment and consumables.

Activity has surged in 2025—129 awards compared to 47 in 2024 and 48 in 2023—reflecting strong demand for diagnostic products across federal healthcare. Within the next twenty-four months, 54 awards with combined potential value of $42.5 million reach ultimate completion, creating recompete opportunity. SCI-reportable invoicing is minimal (only $132 thousand across FY2022–FY2024, with just 0.1 FTEs reported in FY2023), because the vendor's primary federal business is goods procurement rather than labor-intensive services; where service contracts do cross the $150,000 reporting threshold, median hourly rates on government-paid labor run around $968/hr.

The vendor operates as a prime contractor on 100 percent of its award footprint, with negligible subcontractor engagement. Recent sub-awards listed show the vendor itself serving as a subcontractor to Cardinal Health 200, LLC, delivering medical and surgical supplies including blood collection kits and diagnostic test kits—a minor flow relative to the division's dominant prime role. The vendor's NAICS concentration aligns with its core mission: Analytical Laboratory Instrument Manufacturing (694 awards), In-Vitro Diagnostic Substance Manufacturing (268 awards), and Other Electronic and Precision Equipment Repair and Maintenance (241 awards) dominate the award portfolio. Primary PSC codes track similarly—Laboratory Equipment And Supplies (864 awards), Medical And Surgical Instruments, Equipment, And Supplies (644 awards), and In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (448 awards).